Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: Implications for early atherosclerosis

Hypertension Research

Volumn 25, Issue 3, 2002, Pages 475-480

  Furumoto, Tomoo ^a   Saito, Naotaka ^a   Dong, Jie ^a   Mikami, Taisei ^a   Fujii, Satoshi ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Endothelial function; Fibrinolysis; Inflammation; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; INTERLEUKIN 6; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM INJURY; ENDOTHELIUM LESION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; JAPAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; VASODILATATION; ARTERIOSCLEROSIS; BLOOD; DRUG EFFECT; FIBRINOLYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; AGED; ARTERIOSCLEROSIS; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HUMAN; HYPERTENSION; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGE; NITROGLYCERIN; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; TISSUE PLASMINOGEN ACTIVATOR; VASODILATION; HUMANS; MIDDLE AGED;

EID: 0035991469     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.475     Document Type: Article

References (27)

1. Control of blood pressure and lifestyle-related risk factors in elderly Japanese hypertensive subjects
2. Endothelial dysfunction: Does it matter?: Is it reversible?
3. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
4. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
5. Atherosclerosis-an inflammatory disease
6. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease
7. Insulin resistance and thrombosis: A cardiologist's view
8. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
9. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: A potential factor predisposing to thrombosis and its persistence
10. Antihypertensive treatment normalizes decreased endothelium-dependent relaxation in rats with salt-induced hypertension
11. Effects of captopril and enalapril on endothelial function in hypertensive patients
12. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
13. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
14. Preactivated peripheral blood monocytes in patients with essential hypertension
15. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Infection with Chlamydia (ACADEMIC) study
16. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo
17. Effect of bosentan on NF-κB, inflammation, and tissue factor in angiotensin II-induced end-organ damage
18. Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells
19. Triggering of the human interleukin-6 gene by interferon-γ and tumor necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NFγB, and SP1 transcription factors
20. Increased plasminogen activator inhibitor-1 and vasculopathy: A reconcilable paradox
21. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: Direct link between endothelial dysfunction and atherothrombosis
22. The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats
23. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
24. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production
25. Noninvasive, continuous evaluation of peripheral vascular resistance in humans
26. Association of coronary risk factors and endothelium-dependent flow-mediated dilatation of the brachial artery
27. Risk factors and predictors of coronary arterial lesions in Japanese hypertensive patients